TVAMP
GSK icon

Tennessee Valley Asset Management Partners’s GSK GSK Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61
Closed -$2.26K – 367
2023
Q4 		$2.26K Buy
+61
New +$2.19K ﹤0.01% 648

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tennessee Valley Asset Management Partners's GSK Position: Q1 2024 in Review

Tennessee Valley Asset Management Partners sold out of GSK (GSK) in Q1 2024, closing a stake of 61 shares — an estimated $2.26K sold.

Tennessee Valley Asset Management Partners first reported a position in GSK in Q4 2023 and held it in 1 quarter. The position peaked at $2.26K in Q4 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Tennessee Valley Asset Management Partners reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Tennessee Valley Asset Management Partners sold 61 GSK shares in Q1 2024, an estimated $2.26K.
  • Tennessee Valley Asset Management Partners first reported a position in GSK in Q4 2023 and held it in 1 quarter.
  • Tennessee Valley Asset Management Partners's GSK position peaked at $2.26K in Q4 2023.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2024, filed 23 Apr 2024.